Eurazeo Shares Plunge 43% in One Year, Hitting Oversold Territory
Eurazeo shares experienced a sharp decline this Monday midday, trading at 40.34 euros, down 3.17% from last Friday's close. This session's drop is part of a marked downward trend, with the stock having lost nearly 43% over the past year. Concurrently, Goldman Sachs has lowered its price target on the stock.
Immediate Proximity to Support Threshold
Eurazeo is now trading very close to its support level at 39.74 euros. A downward breach of this level could accelerate the selling momentum. The stock is trading significantly below its 50-day (49.35 euros) and 200-day (55.01 euros) moving averages, indicating a bearish dynamic established over several weeks. The RSI, an indicator measuring the relative strength of the stock, stands at 30, marking the conventional boundary of the so-called oversold zone. This level indicates that selling pressure has been particularly intense in recent weeks, although it does not automatically signal a rebound. Over the past week, the stock has declined by 11.57%, with a three-month performance showing a decrease of 23.45%. Meanwhile, the CAC 40 has dropped by 0.05% to 7,907.44 points in a generally cautious market context.
Goldman Sachs Revises Price Target
This Monday, Goldman Sachs revised its price target on Eurazeo, reducing it from 83 euros to 72 euros, while maintaining a buy recommendation. Despite this adjustment, the target set by the American bank remains significantly higher than the current market price of 40.34 euros, representing a potential revaluation of about 78%. The significant gap between Goldman Sachs' valuation and the market price highlights the current discount on the investment company. Key upcoming events to watch include the publication of the first quarter 2026 revenue, scheduled for May 13, preceded by the annual general meeting on May 6. These events could provide additional visibility into the group's operational trajectory.
